What's breaking now, across thousands of outlets.
Aug. 22, 2026 Ionis silences disease at the source Biotech has been hot in 2026. The sector, tracked by the SPDR S&P Biotech ETF, (NYSEMKT: XBI) is up 39% year to date -- beating tech and running even with energy. But it's been volatile, too. Moderna's (NASDAQ: MRNA) 177
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The report estimates India’s alternative investment assets at around $400 billion, including $156 billion in SEBI-registered AIFs, with the rest from offshore vehicles, family offices, and unlisted…
Nifty remained range-bound, falling 0.47% to 24,252 amid subdued volatility. Resistance at 24,450–24,750 remains crucial, while 23,900–24,100 offers support.
This non-discretionary sale to cover RSU withholding obligations reduced his direct stake, but he retains about 106,000 shares valued at $6.49 million.
Nifty Next 50 climbs 2.82% over the month; Nifty 50 rises 2.17%
Key PointsThe transaction involved 41,095 shares executed at a weighted average price of $49.61 per share, representing a total value of $2.0 million.
